将公众号“设为星标”,及时获取更新内容!文丨张桔编辑丨谢长艳近几年,创新药赛道成为医药生物板块中最闪亮的存在,尤其2025年一浪高过一浪的创新药行情吸引了绝大多数股民的关注目光。在创新药下沉的细分赛道中,抗癌领域无疑是重中之重,毕竟这一领域的突破或许会让身患绝症的老百姓看到生的希望。2025年上半年,据中国国家药品监督管理局(NMPA)的药品获批信息统计,今年上半年我国共有22款抗肿瘤药物通过...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.